8.40% 0.10

Gain Therapeutics Inc (GANX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Gain Therapeutics Inc Azioni (GANX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Operating Expenses	12.55% 4.6817	5.3535	4.466	4.7858	5.0895
Operating Income/Loss	12.55% -4.6817	-5.3535	-4.466	-4.7858	-5.0895
Income/Loss From Continuing Operations Before Tax	15.74% -4.5715	-5.4257	-4.4675	-4.7351	-5.6679
Income Tax Expense/Benefit	43.15% 0.1041	0.1831	0.0701	0.5493	0.1412
Net Income/Loss	16.64% -4.6756	-5.6087	-4.5376	-5.2844	-5.8091
Basic Average Shares	1.54% 42.88	42.23	-	35.00	30.34
Diluted Average Shares	1.54% 42.88	42.23	-	35.00	30.34
Basic Earnings Per Share	15.38% -0.11	-0.13	-	-0.15	-0.19
Diluted Earnings Per Share	15.38% -0.11	-0.13	-	-0.15	-0.19

GYRE

$5.86

0.68%

CRMD

$8.10

3.98%

CADL

$8.38

0.12%

DNA

$9.71

3.00%

FDMT

$11.85

6.10%

DSGN

$10.49

2.24%